Lung Cancer Screening: The Views of Patients and Physicians
Location(s): United States
Lung cancer is the leading cause of cancer death in the U.S. among both men and women. Most cases of lung cancer will be discovered at advanced stages. Consequently, great efforts have been made over the last few decades to identify a screening test. After evaluating the benefits and harms, in December 2013 the USPSTF recommended (grade B: high certainty that net benefit is moderate to substantial) annual lung cancer screening with LDCT scans for high-risk patients. The USPSTF recommends that individuals interested in LDCT screening, together with their physicians, should weigh currently known benefits with limitations and risks to make a shared decision about screening for lung cancer. In February 2015, the Centers for Medicare and Medicaid Services provided final support to cover the costs for LDCT.